HEALTH

Healthy Extracts Reports Third Quarter 2023 Results

Retrieved on: 
Tuesday, November 14, 2023
Meal, Sleep, Ultimate Brain, Brain, Acquisition, OTCQB, Calcium, Traction, Diaphragm, Sleep apnea, Marketing, GUT, Ageing, Growth, HEALTH, Rare-earth element, Video game, Life insurance, Insurance, Food delivery, Pharmaceutical industry, Mobile phone, Film industry, Q3

LAS VEGAS, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported results for the three and nine months ended September 30, 2023.

Key Points: 
  • LAS VEGAS, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported results for the three and nine months ended September 30, 2023.
  • Gross margin improved to 80.4% in the third quarter from 48.4% in the previous quarter due to a favorable shift to higher margin sales.
  • This compares to net loss of $170,000 or $(0.00) per basic and diluted share in the same year-ago quarter.
  • “In Q3, we continued to grow our top-line at a healthy double-digit pace as our product offerings, customer subscriptions, and distribution channels continued to expand,” commented Healthy Extracts president, Duke Pitts.

Robbins Geller Rudman & Dowd LLP Announces a Notice of Class Action and Proposed Settlement in the LifeStance Health Group, Inc. Securities Settlement

Retrieved on: 
Wednesday, November 22, 2023
Allocation, Prejudice, William Blair & Company, J.P. Morgan & Co., Pearl Street, Goldman Sachs, Jefferies Group, UBS, COMMON, Fee, L.L.C, District court, Life, CLASS, Settlement, Counsel, Claim, Episcopal conference, Hearing, HEALTH, TPG Inc., Court, ALL

(the "Underwriter Defendants" and, together with the LifeStance Defendants, "Defendants"), have reached a proposed settlement of the claims in the above-captioned class action (the "Action") in the amount of $50,000,000 (the "Settlement").

Key Points: 
  • (the "Underwriter Defendants" and, together with the LifeStance Defendants, "Defendants"), have reached a proposed settlement of the claims in the above-captioned class action (the "Action") in the amount of $50,000,000 (the "Settlement").
  • Any updates regarding the Settlement Hearing, including any changes to the date or time of the hearing, will be posted to the Settlement website, www.LifeStanceSecuritiesSettlement.com .
  • You do NOT need to attend the Settlement Hearing to receive a distribution from the Net Settlement Fund.
  • IF YOU ARE A MEMBER OF THE CLASS, YOUR RIGHTS WILL BE AFFECTED BY THE PROPOSED SETTLEMENT AND YOU MAY BE ENTITLED TO A MONETARY PAYMENT.

InventHelp Inventor Develops Vehicle Accessory to Detect Vital Signs (SGM-251)

Retrieved on: 
Monday, November 13, 2023
Sale, Suite, Health, Safety, HEALTH, Multimedia, Vital signs

The patent-pending invention provides an effective way to monitor the health of a driver.

Key Points: 
  • The patent-pending invention provides an effective way to monitor the health of a driver.
  • In doing so, it would monitor vital signs and notify the driver of a potential problem.
  • The invention features an automatic design that is easy to use so it is ideal for vehicle owners, professional drivers, truck drivers, etc.
  • 22-SGM-251, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext.

HEALTH&BEAUTY, H&B Multi Vitamin Filter Shower Head set launched in Hong Kong

Retrieved on: 
Tuesday, November 7, 2023
Child, Water, Microplastics, Head, Skin, Chlorine, White, ParknShop, Capsule, Taste, HEALTH, Hygiene, Korea, Nutrient, Phosphorus, Perfume

JEONJU-SI, Republic of Korea, Nov. 07, 2023 (GLOBE NEWSWIRE) -- HEALTH&BEAUTY has launched its high-quality H&B Multi Vitamin Filter Shower Head set (多功能維他命過濾式花灑頭) in Hong Kong. This set consists of Multi Vitamin Filter Shower Head, which is an item that ensures cleaner and safer access to tap water.

Key Points: 
  • JEONJU-SI, Republic of Korea, Nov. 07, 2023 (GLOBE NEWSWIRE) -- HEALTH&BEAUTY has launched its high-quality H&B Multi Vitamin Filter Shower Head set (多功能維他命過濾式花灑頭) in Hong Kong.
  • This set consists of Multi Vitamin Filter Shower Head, which is an item that ensures cleaner and safer access to tap water.
  • What differentiates H&B Multi Vitamin Filter Shower Head from other shower heads is the presence of a secondary ring-filter layer.
  • - Multi Vitamin Filter Shower Head Set (White, Black)

Vesica Health Appoints Distinguished Urologic Oncologist Dr. William T. Lowrance to Chief Medical Officer

Retrieved on: 
Tuesday, October 31, 2023
Education minister, Harvard School of Dental Medicine, Survival, Huntsman Cancer Institute, Lee University, Hematuria, MPH, American Urological Association, Public health, Master of Business Administration, Hope, Memorial Sloan Kettering Cancer Center, Medical degree, Prostate cancer, Medical University of South Carolina, Bladder cancer, Bon, MBA, Health, Vesica, Memorial, Disease, Risk, Business administration, Business, University, Public, David Eccles School of Business, Medical school, HEALTH, Lowrance Electronics, Liquid biopsy, Patient, Diagnosis, Associate, Vanderbilt University Medical Center, Harvard T.H. Chan School of Public Health, Pharmaceutical industry, Nursing, Urology, MD, Chemistry

Dr. Lowrance brings more than 20 years of clinical experience, as a professor of urology and a practicing urologic oncologist, treating patients and conducting clinical trials.

Key Points: 
  • Dr. Lowrance brings more than 20 years of clinical experience, as a professor of urology and a practicing urologic oncologist, treating patients and conducting clinical trials.
  • "I have devoted my career to researching and treating urologic cancers, striving to improve patient care and ultimately, survival," said Dr. William T. Lowrance, Chief Medical Officer of Vesica Health.
  • Dr. Lowrance is an attending urologic oncologist at Bon Secours Mercy Health, specializing in the treatment of urologic malignancies, with a focus on bladder cancer.
  • While serving as the Chief Medical Officer of Vesica Health, Dr. Lowrance will continue his medical practice at Bon Secours Mercy Health.

JOHN REED FITNESS DEBUTS IN WEST HOLLYWOOD

Retrieved on: 
Wednesday, October 18, 2023
Food, Disc jockey, LA, JOHN, Boulevard, WEST, Golden Joystick Awards, Open House, West Hollywood, California, Neon, HEALTH, Snack, COMMUNITY, Film industry, Nightclub, Weaving

WEST HOLLYWOOD, Calif., Oct. 18, 2023 /PRNewswire/ -- JOHN REED, the globally celebrated fitness brand renowned for its innovative facilities, lively classes, live DJ sessions, extensive workout choices, and vibrant community, unveils its latest addition in the heart of West Hollywood.

Key Points: 
  • WEST HOLLYWOOD, Calif., Oct. 18, 2023 /PRNewswire/ -- JOHN REED, the globally celebrated fitness brand renowned for its innovative facilities, lively classes, live DJ sessions, extensive workout choices, and vibrant community, unveils its latest addition in the heart of West Hollywood.
  • Located on Santa Monica Blvd in West Hollywood, JOHN REED integrates the WeHo spirit, boasting cutting-edge facilities enriched with art and design for a distinctive club-like ambiance.
  • Committed to revitalizing the local community, JOHN REED aims to be a catalyst for change in West Hollywood.
  • JOHN REED SETS THE STAGE FOR HEALTH, WELLNESS AND COMMUNITY CONNECTION
    "JOHN REED is the club that the West Hollywood community deserves.

TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.

Retrieved on: 
Tuesday, October 17, 2023
Confusion, Growth, Pharmacist, HEALTH, Pharmaceutical industry

Trxade, Inc., a subsidiary of Trxade Health, Inc. (the “Company”), will continue to focus on the pharmaceutical space.

Key Points: 
  • Trxade, Inc., a subsidiary of Trxade Health, Inc. (the “Company”), will continue to focus on the pharmaceutical space.
  • In recent weeks, there may have been some confusion regarding the Company’s strategic direction in the pharmaceutical space.
  • The Company maintains its sole focus on the pharmaceutical sector, providing innovative solutions to address the evolving needs of this industry.
  • We remain committed to providing exceptional service, fostering innovation, and supporting the growth and prosperity of the pharmaceutical space.

Vesica Health Announces the Appointment of Recognized Industry Leaders to Newly Formed Board of Directors

Retrieved on: 
Tuesday, October 17, 2023
Quest Diagnostics, Breast cancer, Harvard University, HEALTH, Communications officer, USS, Liquid biopsy, Research, Quality of life, IVD, NL, USS Fletcher (DD-992), US, Swidler Berlin Shereff Friedman, National Institute for Public Health and the Environment, AkzoNobel, Invitae, Bladder cancer, Corporate development, PCR, Biotechnology, DE, FDA, Berlin, Ventana Medical Systems, Erasmus MC, Genomics, Morgan Stanley Wealth Management, Public health, Sale, International law, Vaccine, General counsel, RIVM, Hematuria, Labcorp, Independent, Duke University, Executive, Roche, Patient, Management, Vesica, EU

"It is with great pleasure that we announce the appointment of Dr. Jan Groen, Mark McDonough, and Joe Sollee to our Board of Directors.

Key Points: 
  • "It is with great pleasure that we announce the appointment of Dr. Jan Groen, Mark McDonough, and Joe Sollee to our Board of Directors.
  • "Based on my experience, Vesica has a singular opportunity to not only take market share but drive widespread clinical adoption of its AssureDx test."
  • "Vesica is uniquely positioned with an impressive portfolio of intellectual property issued both domestically and internationally," commented Joe Sollee.
  • "Speaking on behalf of my fellow Board members, we are excited to be joining Vesica's Board at this important time for the company.

Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales

Retrieved on: 
Thursday, October 12, 2023
Partnership, Kroger, Food technology, HEALTH, Spero, EM News Distribution, Coolhaus, ShopRite, Whole Foods Market, Fast-moving consumer goods, Name, Distribution (marketing), Fairway, Rainforest

Highlights of the New Distribution Partnership:

Key Points: 
  • Highlights of the New Distribution Partnership:
    Superlatus has entered into a strategic collaboration with Rainforest, a leading Direct Store Delivery distributor serving the North Atlantic, Northeast, Midwest, and Mid-Atlantic regions, specializing in better-for-you brands.
  • Superlatus and Rainforest will join forces to introduce Superlatus' products to an extensive network of over 5,000 retail locations, including prominent names such as Whole Foods, Kroger, Moms Organics, ShopRite, Fairway, and more.
  • Rainforest's partnership will provide Superlatus with a distribution ally, enabling increased reach in the high-potential Tri-State area, home to over 33% of the country's consumers.
  • Superlatus CEO, Tim Alford, expressed his enthusiasm about the supplier agreement with Rainforest, emphasizing what this expanded distribution offers Superlatus.

Vesica Health Announces Publication of Study Demonstrating AssureDx Meaningfully Improves Identification of Hematuria Patients at High Risk for Bladder Cancer

Retrieved on: 
Monday, October 9, 2023
OTX1, Probability, AUA, Physician, Department of Urology, University of Virginia, National Capital FreeNet, American Urological Association, TERT, Johns Hopkins University, DNA, Risk, AUC, Capital city, Microhematuria, Urology, Hematuria, Health, HEALTH, Cancer, Carcinoma, TWIST1, Alvin J. Siteman Cancer Center, HRAS, DNA methylation, European Urology, Medical school, Patient, Bladder cancer, FGFR3, Liquid biopsy, Risk assessment, Barnes-Jewish Hospital

The study titled "A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines" was published in the journal European Urology Oncology.

Key Points: 
  • The study titled "A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines" was published in the journal European Urology Oncology.
  • The study analyzed a prospectively collected cohort of 838 hematuria subjects previously tested by AssureDx.
  • Subjects were classified into the AUA risk categories for bladder cancer based on their sex, age, and type of hematuria, also known as urothelial carcinoma (UC).
  • "Publication of this pivotal study in a leading international urology journal, demonstrating AssureDx enhances the AUA Guidelines, underscores the importance of the test for risk stratification of hematuria patients and identification of those at increased risk for bladder cancer," stated Christopher Thibodeau, Chief Executive Officer of Vesica Health.